Literature DB >> 23493823

Insulin therapies: Current and future trends at dawn.

Subhashini Yaturu1.   

Abstract

Insulin is a key player in the control of hyperglycemia for type 1 diabetes patients and selective individuals in patients of type 2 diabetes. Insulin delivery systems that are currently available for the administration of insulin include insulin syringes, insulin infusion pumps, jet injectors and pens. The traditional and most predictable method for the administration of insulin is by subcutaneous injections. The major drawback of current forms of insulin therapy is their invasive nature. To decrease the suffering, the use of supersonic injectors, infusion pumps, sharp needles and pens has been adopted. Such invasive and intensive techniques have spurred the search for alternative, more acceptable methods for administering insulin. Several non-invasive approaches for insulin delivery are being pursued. The newer methods explored include the artificial pancreas with closed-loop system, transdermal insulin, and buccal, oral and pulmonary routes. This review focuses on the new concepts that are being explored for use in future.

Entities:  

Keywords:  Diabetes; Inhaled insulin; Insulin delivery systems; Insulin therapy; Oral insulin; Transdermal insulin

Year:  2013        PMID: 23493823      PMCID: PMC3596776          DOI: 10.4239/wjd.v4.i1.1

Source DB:  PubMed          Journal:  World J Diabetes        ISSN: 1948-9358


  61 in total

Review 1.  The MiniMed Continuous Glucose Monitoring System (CGMS).

Authors:  J Mastrototaro
Journal:  J Pediatr Endocrinol Metab       Date:  1999       Impact factor: 1.634

2.  Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo.

Authors:  Yan Pan; Ying-jian Li; Hui-ying Zhao; Jun-min Zheng; Hui Xu; Gang Wei; Jin-song Hao; Fu-de Cui
Journal:  Int J Pharm       Date:  2002-12-05       Impact factor: 5.875

3.  Formulation pH modulates the interaction of insulin with chitosan nanoparticles.

Authors:  Zengshuan Ma; Hock Hin Yeoh; Lee-Yong Lim
Journal:  J Pharm Sci       Date:  2002-06       Impact factor: 3.534

4.  Hypoglycaemic effect of a novel insulin buccal formulation on rabbits.

Authors:  Hui-Bi Xu; Kai-Xun Huang; Yu-Shan Zhu; Qiu-Hua Gao; Qing-Zhi Wu; Wei-Qun Tian; Xi-Qun Sheng; Ze-Xian Chen; Zhong-Hong Gao
Journal:  Pharmacol Res       Date:  2002-11       Impact factor: 7.658

5.  One to five days of continuous intravenous insulin infusion on seven diabetic patients.

Authors:  G Slama; M Hautecouverture; R Assan; G Tchobroutsky
Journal:  Diabetes       Date:  1974-09       Impact factor: 9.461

6.  Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial.

Authors:  Simon Heller; John Buse; Miles Fisher; Satish Garg; Michel Marre; Ludwig Merker; Eric Renard; David Russell-Jones; Areti Philotheou; Ann Marie Ocampo Francisco; Huiling Pei; Bruce Bode
Journal:  Lancet       Date:  2012-04-21       Impact factor: 79.321

7.  Technosphere/Insulin--proof of concept study with a new insulin formulation for pulmonary delivery.

Authors:  S Steiner; A Pfützner; B R Wilson; O Harzer; L Heinemann; K Rave
Journal:  Exp Clin Endocrinol Diabetes       Date:  2002-01       Impact factor: 2.949

8.  Insulin: discovery and controversy.

Authors:  Louis Rosenfeld
Journal:  Clin Chem       Date:  2002-12       Impact factor: 8.327

9.  A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus.

Authors:  Mary Korytkowski; David Bell; Carol Jacobsen; Rudee Suwannasari
Journal:  Clin Ther       Date:  2003-11       Impact factor: 3.393

Review 10.  Exubera inhaled insulin: a review.

Authors:  A H Barnett
Journal:  Int J Clin Pract       Date:  2004-04       Impact factor: 2.503

View more
  10 in total

1.  Clinical results of an automated artificial pancreas using technosphere inhaled insulin to mimic first-phase insulin secretion.

Authors:  Howard Zisser; Eyal Dassau; Justin J Lee; Rebecca A Harvey; Wendy Bevier; Francis J Doyle
Journal:  J Diabetes Sci Technol       Date:  2015-04-21

2.  Association between glycated hemoglobin and health utility for Type 1 diabetes.

Authors:  R Brett McQueen; Samuel L Ellis; David M Maahs; Heather D Anderson; Kavita V Nair; Anne M Libby; Jonathan D Campbell
Journal:  Patient       Date:  2014       Impact factor: 3.883

Review 3.  Diabetes Technology: Uptake, Outcomes, Barriers, and the Intersection With Distress.

Authors:  Diana Naranjo; Molly L Tanenbaum; Esti Iturralde; Korey K Hood
Journal:  J Diabetes Sci Technol       Date:  2016-06-28

4.  Insulin-like growth factor-1 stimulates regulatory T cells and suppresses autoimmune disease.

Authors:  Daniel Bilbao; Luisa Luciani; Bjarki Johannesson; Agnieszka Piszczek; Nadia Rosenthal
Journal:  EMBO Mol Med       Date:  2014-11       Impact factor: 12.137

Review 5.  Insulin delivery methods: Past, present and future.

Authors:  Rima B Shah; Manhar Patel; David M Maahs; Viral N Shah
Journal:  Int J Pharm Investig       Date:  2016 Jan-Mar

6.  Chitosan-assisted differentiation of porcine adipose tissue-derived stem cells into glucose-responsive insulin-secreting clusters.

Authors:  Hui-Yu Liu; Chih-Chien Chen; Yuan-Yu Lin; Yu-Jen Chen; Bing-Hsien Liu; Shiu-Chung Wong; Cheng-Yu Wu; Yun-Tsui Chang; Han-Yi E Chou; Shih-Torng Ding
Journal:  PLoS One       Date:  2017-03-02       Impact factor: 3.240

Review 7.  Delivery of Insulin via Skin Route for the Management of Diabetes Mellitus: Approaches for Breaching the Obstacles.

Authors:  Abdul Ahad; Mohammad Raish; Yousef A Bin Jardan; Abdullah M Al-Mohizea; Fahad I Al-Jenoobi
Journal:  Pharmaceutics       Date:  2021-01-14       Impact factor: 6.321

8.  Synthesis of an insulin intercalated graphene oxide nanogel composite: evaluation of its release profile and stability for oral delivery of insulin.

Authors:  Shabana Gul Baloch; Huma Shaikh; Shahnila Shah; Shahabuddin Memon; Ayaz Ali Memon
Journal:  Nanoscale Adv       Date:  2022-04-06

9.  Protamine zinc insulin combined with sodium selenite improves glycometabolism in the diabetic KKAy mice.

Authors:  Juan Lu; Wenjun Ji; Mei Zhao; Meng Wang; Wenhui Yan; Mingxia Chen; Shuting Ren; Bingxiang Yuan; Bing Wang; Lina Chen
Journal:  Sci Rep       Date:  2016-05-23       Impact factor: 4.379

10.  Prevention of Postprandial Hyperglycemia by Ophthalmic Nanoparticles Based on Protamine Zinc Insulin in the Rabbit.

Authors:  Saori Deguchi; Fumihiko Ogata; Takumi Isaka; Hiroko Otake; Yosuke Nakazawa; Naohito Kawasaki; Noriaki Nagai
Journal:  Pharmaceutics       Date:  2021-03-12       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.